December 28, 2017 / 12:01 PM / 6 months ago

BRIEF-Jubilant Pharma Updates On USFDA Approval For Draximage® Dtpa​

Dec 28 (Reuters) - Jubilant Pharma Ltd (IPO-JUBI.SI):

* ‍JUBILANT RECEIVES SNDA APPROVAL FOR NEW INDICATIONS FROM USFDA FOR DRAXIMAGE® DTPA​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below